Inlyta and Claritin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Inlyta (axitinib) and Claritin (loratadine). Common drug interactions include haemorrhage among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Inlyta and Claritin. It is created by eHealthMe based on reports of 40 people who take the same drugs from the FDA, and is updated regularly.

What is Inlyta?

Inlyta has active ingredients of axitinib. eHealthMe is studying from 17,662 Inlyta users. Check the latest studies of Inlyta.

What is Claritin?

Claritin has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 77,315 Claritin users. Check the latest studies of Claritin.

On Jul, 13, 2026

40 people who take Inlyta and Claritin together, and have interactions are studied.

What are the common drug interactions of Inlyta and Claritin, by gender? *:

female:

Haemorrhage (bleeding)
Hypersomnia (excessive daytime sleepiness (eds))
Hypertension (high blood pressure)
Inappropriate antidiuretic hormone secretion
Lymphocyte count decreased
Mean platelet volume decreased (less than normal average size of platelet cells in blood)
Nausea (feeling of having an urge to vomit)
Pruritus (severe itching of the skin)
Urticaria (rash of round, red welts on the skin that itch intensely)
Troponin i increased

male:

Diarrhoea
Fatigue (feeling of tiredness)
Hypertension (high blood pressure)
Abdominal distension
Apathy
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Blood pressure increased
Chills (felling of cold)
Decreased appetite
Dry skin

What are the common drug interactions of Inlyta and Claritin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Fatigue (feeling of tiredness)
Increased upper airway secretion
Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)

40-49:

n/a

50-59:

Diarrhoea
Abdominal pain upper
Asthenia (weakness)
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Enterocolonic fistula
Fatigue (feeling of tiredness)
Haematemesis (vomiting of blood)
Haematochezia (passage of stools containing blood)
Haemorrhage (bleeding)
Large intestine perforation (hole in large intestine)

60+:

Nausea (feeling of having an urge to vomit)
Pain in extremity
Eating disorder
Glossodynia (a burning or painful sensation in the tongue)
Pruritus (severe itching of the skin)
Troponin i increased
Headache (pain in head)
Hypertension (high blood pressure)
Abdominal distension
Apathy

What are the existing conditions these people have? *

Renal Cell Carcinoma (a kidney cancer): 24 people, 60.00%
High Blood Pressure: 11 people, 27.50%
Insomnia (sleeplessness): 8 people, 20.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 15.00%
Antiphospholipid Syndrome (disorder that manifests clinically as recurrent venous or arterial thrombosis and/or fetal loss): 6 people, 15.00%
Primary Myelofibrosis (primary disorder of the bone marrow): 6 people, 15.00%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 6 people, 15.00%
Depression: 6 people, 15.00%
Cardiac Failure Congestive: 6 people, 15.00%
Skin Ulcer: 6 people, 15.00%

* Approximation only. Some reports may have incomplete information.

Do you take Inlyta and Claritin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously